Tue 6/2/2020 14:32 ET
DJIA25589.96115.150.45%TELCO169.420.290.17%GOLD1731.6018.351.06%Shanghai2921.405.840.20%
S&P 5003064.428.580.28%BANKS345.661.870.54%OIL35.341.634.61%BITCOIN9513.80601.276.32%
NASDAQ9560.348.600.09%PHARM608.963.470.57%US/EU1.120.000.29%Futures3057.2519.260.63%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Spectrum Pharmaceuticals - SPPI   

Return Top | Return List | Reply Thread | Search | Add SPPI | Ignore SPPI
From: singhtelecom (Rep: 974)Date: 2018-05-11 04:15:24
Forum: Spectrum Pharmaceuticals - Thread #674008635Msg #695 - Part 1/1 (Rec: 0)
ROLONTIS® (eflapegrastim) Phase 3 data abstract to be released by American Society of Clinical Oncology (ASCO) followed by an oral presentation at Multinational Association of Supportive Care in Cancer (MASCC) in June 2018.
Message: Endorse | Reply | Privately | Bookmark | Report Abuse User singhtelecom: Reward | Watch | Ignore


TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.